Cancer Genetics falls after secondary

|About: Cancer Genetics, Inc. (CGIX)|By:, SA News Editor

Cancer Genetics (CGIX.OB -14.4%) plummets after pricing a 1.5M share public offering at $10, a 10% discount to Tuesday's close. (PR)